New Zealand markets closed

Endonovo Therapeutics, Inc. (ENDV)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0024-0.0001 (-4.00%)
At close: 01:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 838.55k
Enterprise value 7.91M
Trailing P/E 0.24
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.12
Price/book (mrq)N/A
Enterprise value/revenue 56.40
Enterprise value/EBITDA 0.89

Trading information

Stock price history

Beta (5Y monthly) -0.36
52-week change 3-76.00%
S&P500 52-week change 321.08%
52-week high 30.0200
52-week low 30.0010
50-day moving average 30.0032
200-day moving average 30.0085

Share statistics

Avg vol (3-month) 31.23M
Avg vol (10-day) 3145.48k
Shares outstanding 5349.39M
Implied shares outstanding 6349.39M
Float 8246.92M
% held by insiders 122.53%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Dec 2019
Ex-dividend date 4N/A
Last split factor 21:1000
Last split date 320 Dec 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-31,105.07%

Management effectiveness

Return on assets (ttm)-144.27%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)255.72k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-86.10%
Gross profit (ttm)N/A
EBITDA -1.97M
Net income avi to common (ttm)-4.4M
Diluted EPS (ttm)0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)7.06M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.00
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-629.9k
Levered free cash flow (ttm)2.15M